mAbxience
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Regulatory, Tech Transfer & Support Services
Chemistry, Manufacturing and Controls
Drug Substance
Analytical & Bioanalytical Services
Clinical Trial Supply & Logistics
Company Overview
About
mAbxience, a Fresenius entity, is a global CDMO with 14+ years of experience in the development and manufacture of biopharmaceuticals, specializing in biosimilars and monoclonal antibodies. They are FDA-registered with two FEI numbers for analysis and API manufacture. They have partnered with HP to develop AI solutions for optimizing monoclonal antibody and biosimilar production. Their CDMO platform offers tailored solutions with quality, agility, and flexibility in manufacturing.
Therapeutic Areas
Oncology
Quick Facts
HQ:Spain
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Fill/Finish (Vials)
Production Scales
Clinical
Markets Served
Global
Manufacturing Facilities
1 site worldwide
mAbxience - Spain Facility
Spain
Site Capabilities
3 capabilitiesSolid Dose Manufacturing
Oral Liquids
Topicals
Clinical Trial Experience
Involvement in 2 clinical trials
Therapeutic Areas
Oncology